Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.

Possible genetic effects on the development of autoimmune thyroid disease were studied by analysis of restriction fragment length polymorphisms (RFLPs) of candidate genes. Peripheral blood leukocyte DNA was obtained from 65 caucasian patients with Graves' disease, 63 caucasian patients with Hashimoto's thyroiditis, and 65 caucasian controls. RFLP analysis was carried out on genomic DNA, using probes for DR beta, DQ alpha, DQ beta, DP alpha, DP beta, T-cell receptor TCR alpha, and thyroid peroxidase. The methodology allowed HLA-DR and DQ typing and provided information on specific RFLP patterns related to T cell receptor (TCR)alpha, DP alpha and -beta, and -beta, and thyroid peroxidase. HLA-DR3 frequency was significantly increased in patients with Graves' disease, as reported previously by others, but neither DNA-derived subtype of DR3 was differentially increased. HLA-DQw2 was also present in increased frequency because of its linkage disequilibrium with HLA-DR3. It is uncertain whether the primary susceptibility is with DQ, DR, or another nearby locus. Susceptibility was not related in these studies to genetic loci recognized in these studies involving DQ alpha, DP, TCR, or thyroid peroxidase. A significant linkage disequilibrium between DR3 and a specific DX alpha RFLP was observed in Graves' disease, but is believed to be representative of a generalized linkage disequilibrium between DR3 and DX alpha, rather than a specific abnormality in Graves' disease. Previous studies indicating association with specific TCR RFLPs could not be reproduced. The relative risk for carriers of HLA-DR3 subtype A in this study was 7.37-fold. RFLP analysis offers the possibility of investigating linkage in a variety of candidate genes as well as established genetic relationships for potentially important subtypes. While the significant relationship with HLA-DR3/DQw2 was reconfirmed, the involvement of other genes or haplotypes could not be established.

[1]  K. Badenhoop,et al.  Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. , 1990, The Journal of clinical endocrinology and metabolism.

[2]  H. Payami,et al.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. , 1989, American journal of human genetics.

[3]  G. Bell,et al.  Disease Associations: Chance, Artifact, or Susceptibility Genes? , 1989, Diabetes.

[4]  R. Spielman,et al.  HLA-DR typing "at the DNA level": RFLPs and subtypes detected with a DR beta cDNA probe. , 1988, American journal of human genetics.

[5]  E. Thompson,et al.  The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. , 1988, American journal of human genetics.

[6]  M. Walport,et al.  T-cell receptor alpha chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' disease. , 1987, Human immunology.

[7]  B. Rapoport,et al.  Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. , 1987, The Journal of clinical investigation.

[8]  T. Kindt,et al.  Segregation of polymorphic T-cell receptor genes in human families. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Tak W. Mak,et al.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains , 1984, Nature.

[10]  C. Auffray,et al.  Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[12]  P. A. Peterson,et al.  HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals , 1983, Nature.

[13]  W. Mayr,et al.  HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  Eric O Long,et al.  Complete sequence of an HLA‐dR beta chain deduced from a cDNA clone and identification of multiple non‐allelic DR beta chain genes. , 1983, The EMBO journal.

[15]  N. Farid,et al.  The human major histocompatibility complex and endocrine disease. , 1981, Endocrine reviews.

[16]  N. Farid,et al.  A study of human leukocyte D locus related antigens in Graves' disease. , 1979, The Journal of clinical investigation.

[17]  J. Konishi,et al.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. , 1974, The Journal of clinical endocrinology and metabolism.